Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
Express Scripts
McKinsey
Harvard Business School

Last Updated: October 6, 2022

Patent: 10,065,993


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,065,993
Title:Peptides and peptide/active compound conjugates for renal targeting
Abstract: The present invention relates to a peptide which consists of more than 50% of sequence sections of the formula -(A.sub.n-B.sub.m-C.sub.o)-, and to a conjugate containing the peptide and at least one covalently bonded active compound, and to a process for the preparation of the conjugate. The present invention furthermore relates to the use of the peptide and the conjugate for targeting of the kidney, and to a medicament comprising the peptide or conjugate.
Inventor(s): Kuebelbeck; Armin (Bensheim, DE), Larbig; Gregor (Gelnhausen, DE), Arnold; Stefan (Muenster, DE), Mier; Walter (Bensheim, DE)
Assignee: MERCK PATENT GMBH (Darmstadt, DE)
Application Number:14/890,059
Patent Claims:see list of patent claims

Details for Patent 10,065,993

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 05/07/2001 See Plans and Pricing 2033-05-07
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 11/14/2014 See Plans and Pricing 2033-05-07
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 10/12/2004 See Plans and Pricing 2033-05-07
Eli Lilly And Company ERBITUX cetuximab Injection 125084 02/12/2004 See Plans and Pricing 2033-05-07
Eli Lilly And Company ERBITUX cetuximab Injection 125084 03/28/2007 See Plans and Pricing 2033-05-07
Genentech, Inc. AVASTIN bevacizumab Injection 125085 02/26/2004 See Plans and Pricing 2033-05-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Baxter
Moodys
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.